novartis glp 1 drug GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients GLP-1 Drug Fails to Quell
Description
Humans have not reported this trend, so it is unclear whether to consider this a risk
Weight loss peptides work best when muscle is preserved, and adequate protein is the primary defense against muscle catabolism during caloric reduction
Patients can still get coverage if they have a diagnosis of Type 2 diabetes, cardiovascular disease or sleep apnea, but not if they have obesity only or for weight loss generally
Multiple clinical trials studying over a dozen therapies failed to show improvement in visual outcomes for NAION patients, with surgical interventions showing no benefit and potentially causing harm
